Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 12:16 AM
NCT ID:
NCT00232258
Eligibility Criteria:
Inclusion Criteria:
* Age at least 18 years
* Ulcerative colitis of at least 6 months duration
* Patient's ulcerative colitis should remain active while taking 5-ASA or sulfasalazine for at least 4 week
* If taking corticosteroids, dose must be stable for at least 2 weeks prior to enrollment and not exceed 20 mg per day (prednisolone equivalent)
Exclusion Criteria:
* Crohn's disease
* Colonic dysplasia
* Stool culture positive for enteric pathogens
* Concurrent cancer or unstable medical condition
* Recent treatment with monoclonal antibody
* Recent introduction of thiazolidinedione
* Recent treatment with methotrexate or cyclosporine
* Recent treatment with an antibiotic prescribed for ulcerative colitis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00232258
Study Brief:
Protocol Section:
NCT00232258